Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

ABSTRACT:

SUBMITTER: Spanjaart AM 

PROVIDER: S-EPMC8573311 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature